SCHEMBL28889367

SCHEMBL28889367

CC(C)c1ccccc1C(C(N)=O)c1cc(C(F)(F)F)ccn1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.41
AURKA O14965 2/20 0.39
EPHX1 P07099 4/20 0.38
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
TRPV3 Q8NET8 1/20 0.38
KCNN4 O15554 1/20 0.38
RIOK2 Q9BVS4 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
NR3C2 P08235 1/20 0.36
ALDH1A1 P00352 2/20 0.35
FPR2 P25090 1/20 0.35
SCN9A Q15858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28889339 0.89 ADRB2 (0.42) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL28959168 0.86 HDAC4 (0.44) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL28994016 0.85 ADRB2 (0.40) ADRB2TRPV3
SCHEMBL28889221 0.85 ADRB2 (0.41) ADRB2NOS3NOS2TRPV3NPSR1
SCHEMBL28889283 0.84 ADRB2 (0.41) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL28889298 0.82 ADRB2 (0.39) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL24110333 0.82 TACR1 (0.45) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL28889281 0.82 KMT2A (0.40) ADRB2TRPV3KCNN4RIOK2ALDH1A1
SCHEMBL28889307 0.81 ADRB2 (0.38) ADRB2AURKAEPHX1NOS3NOS2
SCHEMBL28889381 0.81 ADRB2 (0.39) ADRB2NOS3NOS2TRPV3KCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022222911-A1 PYRIMIDONE COMPOUND AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-10-27 WO disclosed
CN-115215862-A Pyrimidone compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-21 CN disclosed